MeMed Severity™
MeMed Severity is a revolutionary test for patients presenting with suspected acute infection or sepsis. It generates a numeric score indicating the likelihood of progressing to severe outcomes.
This device is currently in development and has not been approved for sale by any regulatory authority. The information provided here is for informational purposes only and is not intended to substitute for professional medical advice, diagnosis, or treatment.
Sepsis - A global health problem
related to sepsis¹
outcome for every 1-hour delay in
treatment³
when sepsis presented at admission,
$51K in cases of late detection⁴
How It Works
MeMed Severity runs on the MeMed Key®, a cutting edge, compact immunoassay platform that makes it possible to conduct highly sensitive, rapid, multiplexed protein measurements that previously could only be done on large, expensive central lab equipment.
Quick turnaround time (<15 min)
Low sample volume
Easy to Use
Results display
The test categorizes patients into five distinct bins based on the numeric score.
Lower Bins:
Assisting clinicians in making safe discharge decisions, complementing clinical judgment.
Upper Bin: Prompting advanced care, optimizing resource allocation, and improving patient outcomes.
MeMed BV
and MeMed Severity™ Interplay⁶
The paradigm for sepsis management is shifting to a more comprehensive approach. By integrating MeMed BV and MeMed Severity into current workflows and standard of care, clinicians could more accurately assess likelihood of bacterial infections and progression to severe outcomes.
MeMed Severity™ brings value to care providers,
health systems, and patients
Immediate Risk Assessment
Support triage and evaluation in the Emergency Department (ED), providing crucial information for immediate decision-making.
Short-Term Prognosis
Offer prognostic information within 72 hours, aiding in patient disposition and referral decisions to ensure optimal care pathways.
Disease Monitoring
Potentially guide treatment escalation or de-escalation for hospitalized patients to ensure appropriate care.
Potentially Improve Patient Outcomes
Appropriate supportive care and disposition
Early and informed treatment decisions
Avoid unnecessary interventions and hospitalization
Economical Value
Early detection may reduce complications and treatment costs
Potentially reduce re-admissions, hospital LOS, diagnostic tests and associated burden
Reduce Clinical Burden
Improve resource utilization while minimizing alert fatigue
Aids in increasing ED patient throughput and reduction of ED LOS
Schedule a demo
References
1. Key facts about sepsis. World Health Organization. https://www.who.
2. Gadre SK, Shah M, Mireles-Cabodevila E, Patel B, Duggal A. Epidemiology and Predictors of 30-Day Readmission in Patients With Sepsis. Chest. 2019 Mar;155(3):483-490.
3. Seymour CW, Kahn JM, Martin-Gill C, Callaway CW, Yealy DM, Scales D, Angus DC. Delays From First Medical Contact to Antibiotic Administration for Sepsis. Crit Care Med. 2017 May;45(5):759-765
4. Paoli CJ, Reynolds MA, Sinha M, Gitlin M, Crouser E. Epidemiology and Costs of Sepsis in the United States-An Analysis Based on Timing of Diagnosis and Severity Level. Crit Care Med. 2018 Dec;46(12):1889-1897.
5. Epic’s sepsis algorithm may cause alert fatigue. FIERCE Healthcare. Link
6. Surviving Sepsis Campaign Guidelines 2021. Society of Critical Care Medicine, 2021
© 2024 MeMed, Ltd. All rights reserved.